Merino de Paz, N.; Quevedo-Abeledo, J.C.; Gómez-Bernal, F.; de Vera-González, A.; Abreu-González, P.; Martín-González, C.; González-Gay, M.Á.; Ferraz-Amaro, I.
Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. J. Clin. Med. 2024, 13, 901.
https://doi.org/10.3390/jcm13030901
AMA Style
Merino de Paz N, Quevedo-Abeledo JC, Gómez-Bernal F, de Vera-González A, Abreu-González P, Martín-González C, González-Gay MÁ, Ferraz-Amaro I.
Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. Journal of Clinical Medicine. 2024; 13(3):901.
https://doi.org/10.3390/jcm13030901
Chicago/Turabian Style
Merino de Paz, Nayra, Juan Carlos Quevedo-Abeledo, Fuensanta Gómez-Bernal, Antonia de Vera-González, Pedro Abreu-González, Candelaria Martín-González, Miguel Ángel González-Gay, and Iván Ferraz-Amaro.
2024. "Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients" Journal of Clinical Medicine 13, no. 3: 901.
https://doi.org/10.3390/jcm13030901
APA Style
Merino de Paz, N., Quevedo-Abeledo, J. C., Gómez-Bernal, F., de Vera-González, A., Abreu-González, P., Martín-González, C., González-Gay, M. Á., & Ferraz-Amaro, I.
(2024). Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. Journal of Clinical Medicine, 13(3), 901.
https://doi.org/10.3390/jcm13030901
